SEE-THROUGH DISPLAY FOR AN AUGMENTED REALITY SYSTEM

    公开(公告)号:WO2020065380A1

    公开(公告)日:2020-04-02

    申请号:PCT/IB2018/057504

    申请日:2018-09-27

    Abstract: An optical system for a see-through display includes a stack of metasurface layers configured to receive light constituting an image; and a waveguide coupled to the stack. Each layer in the stack of metasurface layers is configured to provide a resonant response to an optical field at a different spectral band and to couple the resonant response with a waveguide. The waveguide is configured to propagate the different spectral bands in a direction of a user's eye.

    REAL-TIME DISPLAY OF TREATMENT-RELATED TISSUE CHANGES USING VIRTUAL MATERIAL

    公开(公告)号:WO2018092063A1

    公开(公告)日:2018-05-24

    申请号:PCT/IB2017/057176

    申请日:2017-11-16

    Abstract: In some embodiments, data sensed and/or operational parameters used during a catheterization procedure are used in the motion frame-rate updating and visual rendering of a simulated organ geometry. The organ geometry is rendered as a virtual material using a software environment (preferably a graphical game engine) which applies simulated optical laws to material appearance parameters affecting the virtual material's visual appearance, as part of simulating a scene comprising the simulated organ geometry, and optionally also comprising simulated views of a catheter probe used for sensing and/or treatment. Optionally, measurements of and/or effects on tissue by sensing and/or commanded probe-tissue interactions are converted into material appearance changes, allowing dynamic visual simulation of intra-body states and/or events based on optionally non- visual input data. In some embodiments, physiology, motion physics, and/or other physical processes are simulated based on live inputs as part of associating material appearance properties to the simulated tissue's geometry.

    METHODS OF PURIFYING AND QUALIFYING ANTIBODIES
    8.
    发明申请
    METHODS OF PURIFYING AND QUALIFYING ANTIBODIES 审中-公开
    纯化和鉴定抗体的方法

    公开(公告)号:WO2018051348A1

    公开(公告)日:2018-03-22

    申请号:PCT/IL2017/051044

    申请日:2017-09-14

    Inventor: MIRON, Daphna

    Abstract: A method of purifying a recombinant antibody having the complementarity determining regions (CDRs) of denosumab, the method comprising subjecting a preparation comprising said antibody to a mixed mode chromatography on a Capto™ Adhere column in a p H range of 6.2-7.4, thereby purifying the antibody.

    Abstract translation: 纯化具有狄诺塞麦的互补决定区(CDR)的重组抗体的方法,所述方法包括使包含所述抗体的制剂经历在ap H范围内的Capto TM Adhere柱上的混合模式色谱 6.2-7.4,从而纯化抗体。

    CHARACTERISTIC TRACK CATHETER NAVIGATION
    9.
    发明申请
    CHARACTERISTIC TRACK CATHETER NAVIGATION 审中-公开
    特点履带导管导航

    公开(公告)号:WO2018011757A1

    公开(公告)日:2018-01-18

    申请号:PCT/IB2017/054263

    申请日:2017-07-14

    Abstract: Registration of catheter-sensed intrabody voltage field measurements obtained along one or more tracks of catheter advance of withdrawal is made, in some embodiments, to reference voltage field measurements lying along predetermined tracks. Tracks optionally comprise the course of a blood vessel such as the superior or inferior vena cava, a path defined and/or limited by encounters with a wall of a heart chamber and/or apertures thereof, and/or another track of catheter motion. In some embodiments, transform parameters are propagated to regions away from the track, potentially allowing more rapid acquisition of targets.

    Abstract translation: 在一些实施例中,沿着一个或多个撤回的导管推进轨道获得的导管感测的体内电压场测量结果的记录在沿着预定轨迹的基准电压场测量中进行。 轨道可选地包括诸如上腔静脉或下腔静脉之类的血管的路线,通过与心脏腔壁和/或其孔相遇和/或与导管运动的另一轨道相遇而限定和/或限制的路径。 在一些实施例中,变换参数被传播到远离轨道的区域,潜在地允许更快速地采集目标。

Patent Agency Ranking